PROCEFTAZO 1125 INJ is a powerful combination antibiotic injection formulated with Ceftriaxone & Tazobactam for Injection 1125 mg, designed to treat a wide range of serious bacterial infections. This advanced formulation combines a third-generation cephalosporin antibiotic (Ceftriaxone) with a beta-lactamase inhibitor (Tazobactam), enhancing its effectiveness against resistant bacterial strains.
In today’s clinical environment, antibiotic resistance is a growing concern. Many bacteria have developed mechanisms to neutralize standard antibiotics, making infections harder to treat. PROCEFTAZO 1125 INJ addresses this issue by incorporating Tazobactam, which protects Ceftriaxone from enzymatic degradation, ensuring optimal antibacterial activity.
This injectable medication is commonly prescribed in hospitals and clinical settings for moderate to severe infections, where oral antibiotics may not be effective. It is administered under medical supervision and is known for its rapid action, broad-spectrum coverage, and reliable clinical outcomes.
Uses
PROCEFTAZO 1125 INJ is widely used for the treatment of various bacterial infections affecting different parts of the body. Its broad-spectrum nature makes it effective against both Gram-positive and Gram-negative bacteria.
Common Uses Include:
Respiratory Tract Infections
Such as pneumonia, bronchitis, and lung abscesses.Urinary Tract Infections (UTIs)
Including complicated and recurrent infections.Intra-abdominal Infections
Like peritonitis and infections of the liver or gallbladder.Skin and Soft Tissue Infections
Including cellulitis, wound infections, and abscesses.Bone and Joint Infections
Such as osteomyelitis and septic arthritis.Septicemia (Bloodstream Infections)
A serious condition requiring immediate antibiotic therapy.Gynecological Infections
Including pelvic inflammatory disease.Post-Surgical Infections
Used as both treatment and prophylaxis in surgeries.Meningitis
Infection of the brain and spinal cord membranes.
This injection is particularly useful in hospital settings where resistant infections are suspected or confirmed.
Benefits
PROCEFTAZO 1125 INJ offers several clinical and therapeutic advantages that make it a preferred choice among healthcare professionals.
1. Broad-Spectrum Antibacterial Activity
The combination of Ceftriaxone and Tazobactam ensures effectiveness against a wide range of bacteria, including resistant strains.
2. Enhanced Efficacy Against Resistant Bacteria
Tazobactam inhibits beta-lactamase enzymes produced by bacteria, preventing the breakdown of Ceftriaxone and improving its potency.
3. Rapid Onset of Action
Being an injectable formulation, it provides faster therapeutic effects compared to oral antibiotics.
4. Suitable for Severe Infections
Ideal for treating life-threatening infections such as sepsis, meningitis, and complicated pneumonia.
5. Reduced Risk of Treatment Failure
The dual-action mechanism minimizes the chances of bacterial resistance and treatment failure.
6. Convenient Dosing in Clinical Settings
Usually administered once or twice daily, making it convenient for hospital use.
7. Trusted in Surgical Prophylaxis
Helps prevent infections during and after surgical procedures.
Dosage
The dosage of PROCEFTAZO 1125 INJ should always be determined by a qualified healthcare professional based on the patient’s condition, severity of infection, age, and medical history.
General Dosage Guidelines:
Adults:
Typically administered once or twice daily depending on the severity of infection.Children:
Dosage is adjusted based on body weight and medical condition.Route of Administration:
Intravenous (IV)
Intramuscular (IM)
Important Instructions:
Always administered by a doctor or trained healthcare provider.
Do not self-administer this injection.
Complete the full course of treatment even if symptoms improve early.
Skipping doses or stopping early may lead to antibiotic resistance.
Special Considerations:
Dose adjustments may be required in patients with kidney or liver impairment.
Elderly patients may require careful monitoring.
Side Effects
Like all medications, PROCEFTAZO 1125 INJ may cause some side effects. Most are mild and temporary, but some may require medical attention.
Common Side Effects:
Pain or swelling at the injection site
Nausea and vomiting
Diarrhea
Mild skin rash
Headache
Less Common Side Effects:
Fever
Dizziness
Changes in liver enzyme levels
Allergic reactions (rash, itching)
Serious Side Effects (Seek Immediate Medical Help):
Severe allergic reactions (anaphylaxis)
Difficulty breathing
Severe diarrhea (possible Clostridium difficile infection)
Yellowing of skin or eyes (jaundice)
Unusual bleeding or bruising
If any severe or persistent side effects occur, immediate medical consultation is necessary.
Precautions and Warning
Before using PROCEFTAZO 1125 INJ, certain precautions should be taken to ensure safety and effectiveness.
1. Allergy Check
Inform your doctor if you are allergic to cephalosporins, penicillins, or any beta-lactam antibiotics.
2. Kidney and Liver Disorders
Patients with renal or hepatic impairment should use this medicine with caution.
Dose adjustments may be required.
3. Pregnancy and Breastfeeding
Use only if prescribed by a doctor.
Should be used cautiously during pregnancy and lactation.
4. Drug Interactions
Inform your doctor about all medications you are taking, including:
Blood thinners
Other antibiotics
Diuretics
5. Alcohol Consumption
Avoid alcohol during treatment as it may worsen side effects.
6. Antibiotic Resistance
Do not misuse or overuse antibiotics.
Always follow the prescribed course.
7. Gastrointestinal Conditions
Use cautiously in patients with a history of colitis or severe diarrhea.
8. Pediatric and Geriatric Use
Requires careful dose monitoring in children and elderly patients.
Conclusion
PROCEFTAZO 1125 INJ Ceftriaxone & Tazobactam For Injection 1125 mg is a highly effective, broad-spectrum antibiotic solution designed to combat a wide range of bacterial infections, including those caused by resistant organisms. Its dual-action formula ensures enhanced efficacy, rapid recovery, and reduced risk of treatment failure.
With its proven clinical performance, this injection is widely trusted by healthcare professionals for treating severe infections in hospital settings. However, like all antibiotics, it must be used responsibly under medical supervision to prevent resistance and ensure optimal outcomes.
